股本结构
单位：万股
| 公告日期 | 2024-04-08 | 2024-03-08 | 2024-03-08 | 2023-11-07 | 2023-11-07 | 2023-08-01 |
|---|---|---|---|---|---|---|
| 证券总股本 | 2378.62 | 2354.95 | 2337.84 | 2335.34 | 2335.10 | 2335.16 |
| 普通股本 | 2378.62 | 2354.95 | 2337.84 | 2335.34 | 2335.10 | 2335.16 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2024-04-04 | 2024-03-01 | 2023-12-31 | 2023-11-03 | 2023-09-30 | 2023-07-28 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2024-04-08 | 2378.62 | 未披露 | 定期报告 | 2024-04-04 |
| 2024-03-08 | 2354.95 | 未披露 | 定期报告 | 2024-03-01 |
| 2024-03-08 | 2337.84 | 未披露 |
更多>>
From December 31,2022 to December 31,2023
Restricted stock
Stock option exercise
Consideration for MedTech and Rhino acquisitions
Stock portion of ApiFix anniversary installment payment
|
2023-12-31 |
| 2023-11-07 | 2335.34 | 未披露 | 定期报告 | 2023-11-03 |
| 2023-11-07 | 2335.10 | 未披露 |
更多>>
From June 30, 2023 to September 30, 2023
Stock option exercise
Restricted stock
Consideration for Rhino
|
2023-09-30 |
| 2023-08-01 | 2335.16 | 未披露 | 定期报告 | 2023-07-28 |
| 2023-08-01 | 2334.05 | 未披露 |
更多>>
From March 31, 2023 to June 30, 2023
Consideration for MedTech acquisition
Stock portion of ApiFix anniversary installment
Restricted stock
|
2023-06-30 |
| 2023-05-02 | 2332.72 | 未披露 | 定期报告 | 2023-05-01 |
| 2023-04-28 | 2328.38 | 未披露 | 定期报告 | 2023-04-24 |
| 2023-05-02 | 2314.21 | 未披露 |
更多>>
From January 1, 2023 to March 31, 2023
Restricted stock
|
2023-03-31 |
| 2023-03-01 | 2299.34 | 未披露 | 定期报告 | 2023-02-27 |
| 2023-03-01 | 2287.80 | 未披露 |
更多>>
From December 31, 2021 to December 31, 2022
Stock option exercise
Restricted stock
Stock portion of Apifix anniversary installment payment
Consideration for MD Ortho and Pega acquisitions
Issuance of common stock, net of issuance cost
|
2022-12-31 |
| 2022-11-01 | 2289.15 | 未披露 | 定期报告 | 2022-10-28 |
| 2022-11-01 | 2289.60 | 未披露 |
更多>>
From June 30, 2022 to September 30, 2022
Stock option exercise
Restricted stock
Issuance of common stock, net of issuance cost
Issuance of unregistered shares
|
2022-09-30 |
| 2022-08-12 | 2102.82 | 未披露 |
更多>>
1.Common stock offered by 750,000 shares
|
2022-08-15 |
| 2022-08-04 | 2027.82 | 未披露 | 定期报告 | 2022-08-02 |
| 2022-08-04 | 2023.89 | 未披露 |
更多>>
From March 31, 2022 to June 30, 2022
Stock option exercise
Restricted stock
Consideration for MD Ortho acquisition
Stock portion of ApiFix anniversary installment payment
|
2022-06-30 |
| 2022-05-05 | 2022.99 | 未披露 | 定期报告 | 2022-05-03 |
| 2022-04-15 | 2023.00 | 未披露 | 定期报告 | 2022-04-11 |
| 2022-04-04 | 1982.14 | 未披露 | 定期报告 | 2022-04-01 |
| 2022-05-05 | 1982.13 | 未披露 |
更多>>
From January 1, 2022 to March 31, 2022
Restricted stock
|
2022-03-31 |
| 2022-03-03 | 1974.53 | 未披露 | 定期报告 | 2022-03-01 |
| 2022-03-03 | 1967.72 | 未披露 |
更多>>
From December 31, 2020 to December 31, 2021
Stock option exercise
Restricted stock
Consideration for Devise Ortho acquired assets
|
2021-12-31 |
| 2021-11-04 | 1967.84 | 未披露 | 定期报告 | 2021-11-02 |
| 2021-11-04 | 1967.22 | 未披露 |
更多>>
From June 30, 2021 to September 30, 2021
Stock option exercise
Restricted stock
|
2021-09-30 |
| 2021-08-05 | 1967.26 | 未披露 | 定期报告 | 2021-08-03 |
| 2021-08-05 | 1967.00 | 未披露 |
更多>>
From March 31, 2021 to June 30, 2021
Restricted stock
|
2021-06-30 |
| 2021-05-06 | 1965.90 | 未披露 | 定期报告 | 2021-05-04 |
| 2021-05-06 | 1965.94 | 未披露 |
更多>>
From December 31, 2020 to March 31, 2021
Stock option exercise
Restricted stock
|
2021-03-31 |
| 2021-03-11 | 1965.83 | 未披露 | 定期报告 | 2021-03-09 |
| 2021-03-11 | 1956.03 | 未披露 |
更多>>
from December 31, 2019 to December 31, 2020
Restricted stock
Stock option exercise
Consideration for ApiFix and Telos acquisitions and Band-Lok intellectual property purchase
Issuance of common stock, net of issuance cost
|
2020-12-31 |
| 2020-11-05 | 1955.46 | 未披露 |
更多>>
From June 30, 2020 to September 30, 2020
Stock option exercise
Restricted stock
|
2020-09-30 |
| 2020-08-06 | 1954.92 | 未披露 | 定期报告 | 2020-08-04 |
| 2020-08-06 | 1954.00 | 未披露 |
更多>>
From March 31, 2020 to June 30, 2020
Stock option exercise
Restricted stock
Consideration for ApiFix acquisition and Band-Lok intellectual property purchase
Issuance of common stock, net of issuance cost
|
2020-06-30 |
| 2020-06-22 | 1947.28 | 未披露 |
更多>>
1.Common stock offered by the company 1,600,000 shares
2.The number of shares of our common stock to be outstanding after this offering set forth above is based on 16,883,660 shares of common stock outstanding as of March 31, 2020
|
2020-06-22 |
| 2020-04-17 | 1781.84 | 未披露 | 定期报告 | 2020-04-15 |
| 2020-05-06 | 1688.37 | 未披露 |
更多>>
from January 1, 2020 to March 31, 2020
Stock option exercise
Restricted stock
Consideration for Telos Acquisition
Repurchase of common stock
|
2020-03-31 |
| 2020-03-05 | 1688.12 | 未披露 | 定期报告 | 2020-03-03 |
| 2020-03-05 | 1672.31 | 未披露 |
更多>>
from December 31, 2018 to December 31, 2019
Consideration for Vilex and Orthex Acquisition
Restricted stock
Stock option exercise
Issuance of common stock, net of issuance cost
|
2019-12-31 |
| 2019-12-13 | 1648.71 | 未披露 | 定期报告 | 2019-12-13 |
| 2019-11-08 | 1496.71 | 未披露 |
更多>>
from June 30, 2019 to September 30, 2019
Stock option exercise
Restricted stock
|
2019-09-30 |
| 2019-08-13 | 1493.96 | 未披露 | 定期报告 | 2019-08-12 |
| 2019-08-13 | 1493.95 | 未披露 |
更多>>
from March 31, 2019 to June 30, 2019
Acquisition consideration
Stock option exercise
Restricted stock
|
2019-06-30 |
| 2019-05-09 | 1467.80 | 未披露 | 定期报告 | 2019-05-08 |
| 2019-05-09 | 1468.24 | 未披露 |
更多>>
from January 1, 2019 to March 31, 2019
Stock option exercise
Restricted stock
|
2019-03-31 |
| 2019-03-07 | 1467.72 | 未披露 | 定期报告 | 2019-03-06 |
| 2019-03-07 | 1453.82 | 未披露 |
更多>>
from December 31, 2017 to December 31, 2018
Issuance of common stock, net of issuance cost
Restricted stock
Stock option exercise
|
2018-12-31 |
| 2018-10-31 | 1281.15 | 未披露 | 定期报告 | 2018-10-29 |
| 2018-10-31 | 1280.75 | 未披露 |
更多>>
from January 1, 2018 to September 30, 2018
Stock option exercise
Restricted stock
|
2018-09-30 |
| 2018-08-09 | 1279.03 | 未披露 | 定期报告 | 2018-08-08 |
| 2018-08-09 | 1262.18 | 未披露 |
更多>>
From January 1, 2018 to June 30, 2018
Restricted stock
|
2018-06-30 |
| 2018-05-15 | 1277.23 | 未披露 | 定期报告 | 2018-05-11 |
| 2018-04-27 | 1277.28 | 未披露 | 定期报告 | 2018-04-23 |
| 2018-05-15 | 1277.08 | 未披露 |
更多>>
From January 1, 2018 to March 15, 2018
Restricted stock
|
2018-03-15 |
| 2018-03-15 | 1262.18 | 未披露 |
更多>>
from December 31, 2016 to December 31, 2017
Conversion of redeemable preferred shares to common stock upon IPO
Restricted stock
Shares surrendered by employees to pay taxes on restricted stock
Conversion of Series A redeemable preferred stock dividends to common stock upon IPO
Series A redeemable preferred stock liquidation preference payment
Issuance of common stock, net of issuance cost
|
2017-12-31 |
| 2017-11-13 | 1269.80 | 未披露 | 定期报告 | 2017-11-09 |
| 2017-10-12 | 1204.44 | 未披露 |
更多>>
1.Common stock offered by us:4,000,000 shares
2.The number of shares of our common stock to be outstanding after this offering set forth above is based on 2,481,607 shares outstanding as of June 30, 2017
3.gives effect to the one-for-0.67 reverse stock split of our common stock that was consummated on October 5, 2017
|
2017-10-12 |
| 2017-11-13 | 248.76 | 544.70 |
更多>>
from December 31, 2016 to September 30, 2017
Restricted stock
|
2017-09-30 |
| 2017-10-10 | 248.16 | 544.70 |
更多>>
from December 31, 2016 to June 30, 2017
Restricted stock
|
2017-06-30 |
| 2016-06-16 | 360.96 | 544.70 |
更多>>
from December 31, 2015 to March 31, 2016
Restricted stock
|
2016-03-31 |
From December 31,2022 to December 31,2023
Restricted stock
Stock option exercise
Consideration for MedTech and Rhino acquisitions
Stock portion of ApiFix anniversary installment payment
From June 30, 2023 to September 30, 2023
Stock option exercise
Restricted stock
Consideration for Rhino
From March 31, 2023 to June 30, 2023
Consideration for MedTech acquisition
Stock portion of ApiFix anniversary installment
Restricted stock
From January 1, 2023 to March 31, 2023
Restricted stock
From December 31, 2021 to December 31, 2022
Stock option exercise
Restricted stock
Stock portion of Apifix anniversary installment payment
Consideration for MD Ortho and Pega acquisitions
Issuance of common stock, net of issuance cost
From June 30, 2022 to September 30, 2022
Stock option exercise
Restricted stock
Issuance of common stock, net of issuance cost
Issuance of unregistered shares
1.Common stock offered by 750,000 shares
From March 31, 2022 to June 30, 2022
Stock option exercise
Restricted stock
Consideration for MD Ortho acquisition
Stock portion of ApiFix anniversary installment payment
From January 1, 2022 to March 31, 2022
Restricted stock
From December 31, 2020 to December 31, 2021
Stock option exercise
Restricted stock
Consideration for Devise Ortho acquired assets
From June 30, 2021 to September 30, 2021
Stock option exercise
Restricted stock
From March 31, 2021 to June 30, 2021
Restricted stock
From December 31, 2020 to March 31, 2021
Stock option exercise
Restricted stock
from December 31, 2019 to December 31, 2020
Restricted stock
Stock option exercise
Consideration for ApiFix and Telos acquisitions and Band-Lok intellectual property purchase
Issuance of common stock, net of issuance cost
From June 30, 2020 to September 30, 2020
Stock option exercise
Restricted stock
From March 31, 2020 to June 30, 2020
Stock option exercise
Restricted stock
Consideration for ApiFix acquisition and Band-Lok intellectual property purchase
Issuance of common stock, net of issuance cost
1.Common stock offered by the company 1,600,000 shares
2.The number of shares of our common stock to be outstanding after this offering set forth above is based on 16,883,660 shares of common stock outstanding as of March 31, 2020
from January 1, 2020 to March 31, 2020
Stock option exercise
Restricted stock
Consideration for Telos Acquisition
Repurchase of common stock
from December 31, 2018 to December 31, 2019
Consideration for Vilex and Orthex Acquisition
Restricted stock
Stock option exercise
Issuance of common stock, net of issuance cost
from June 30, 2019 to September 30, 2019
Stock option exercise
Restricted stock
from March 31, 2019 to June 30, 2019
Acquisition consideration
Stock option exercise
Restricted stock
from January 1, 2019 to March 31, 2019
Stock option exercise
Restricted stock
from December 31, 2017 to December 31, 2018
Issuance of common stock, net of issuance cost
Restricted stock
Stock option exercise
from January 1, 2018 to September 30, 2018
Stock option exercise
Restricted stock
From January 1, 2018 to June 30, 2018
Restricted stock
From January 1, 2018 to March 15, 2018
Restricted stock
from December 31, 2016 to December 31, 2017
Conversion of redeemable preferred shares to common stock upon IPO
Restricted stock
Shares surrendered by employees to pay taxes on restricted stock
Conversion of Series A redeemable preferred stock dividends to common stock upon IPO
Series A redeemable preferred stock liquidation preference payment
Issuance of common stock, net of issuance cost
1.Common stock offered by us:4,000,000 shares
2.The number of shares of our common stock to be outstanding after this offering set forth above is based on 2,481,607 shares outstanding as of June 30, 2017
3.gives effect to the one-for-0.67 reverse stock split of our common stock that was consummated on October 5, 2017
from December 31, 2016 to September 30, 2017
Restricted stock
from December 31, 2016 to June 30, 2017
Restricted stock
from December 31, 2015 to March 31, 2016
Restricted stock